Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Nov;33(11):1845–1854. doi: 10.1128/aac.33.11.1845

BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

R J Wallace Jr 1, V A Steingrube 1, D R Nash 1, D G Hollis 1, C Flanagan 1, B A Brown 1, A Labidi 1, R E Weaver 1
PMCID: PMC172775  PMID: 2514622

Abstract

Two closely related beta-lactamases, BRO-1 and BRO-2 (formerly called Ravasio and 1908), are found in Moraxella (Branhamella) catarrhalis. We screened strains of B. catarrhalis recovered in the United States since 1952 and identified the first beta-lactamase-positive isolate in August 1976. The prevalence of the enzymes among 394 clinical isolates from one Texas hospital has averaged 75% since testing began in 1983. Screening of isolates of Moraxella subgenus Moraxella revealed the BRO enzymes in two other human respiratory tract species, M. lacunata and M. nonliquefaciens, beginning in 1978. A different beta-lactamase with a pI of 6.4 predominated in other species of subgenus Moraxella. BRO-2 had a different isoelectric focusing pattern and was produced in lesser amounts than BRO-1, but the two enzymes were indistinguishable by substrate or inhibitor profile. BRO enzymes from B. catarrhalis, M. nonliquefaciens, and M. lacunata could be transferred by conjugation and, for B. catarrhalis, also by transformation to B. catarrhalis. Plasmid bands were demonstrated in 90% of M. nonliquefaciens and in one previously reported strain of B. catarrhalis, but no change in plasmid profiles was seen in beta-lactamase-positive recombinants, supporting previous studies that suggested the beta-lactamase genes are chromosomal.

Full text

PDF
1845

Images in this article

1849Image
on p.1849
1850Image
on p.1850
1851Image
on p.1851
1851Image
on p.1851

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez S., Jones M., Holtsclaw-Berk S., Guarderas J., Berk S. L. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis. Antimicrob Agents Chemother. 1985 Apr;27(4):646–647. doi: 10.1128/aac.27.4.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beaulieu D., Ouellette M., Bergeron M. G., Roy P. H. Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B. catarrhalis strain. Plasmid. 1988 Sep;20(2):158–162. doi: 10.1016/0147-619x(88)90020-0. [DOI] [PubMed] [Google Scholar]
  3. Bhaduri S., Demchick P. H. Simple and rapid method for disruption of bacteria for protein studies. Appl Environ Microbiol. 1983 Oct;46(4):941–943. doi: 10.1128/aem.46.4.941-943.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biswas G. D., Blackman E. Y., Sparling P. F. High-frequency conjugal transfer of a gonococcal penicillinase plasmid. J Bacteriol. 1980 Sep;143(3):1318–1324. doi: 10.1128/jb.143.3.1318-1324.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bovre K. Oxidase positive bacteria in the human nose incidence and species distribution, as diagnosed by genetic transformation. Acta Pathol Microbiol Scand B Microbiol Immunol. 1970;78(6):780–784. [PubMed] [Google Scholar]
  6. Bush K. Characterization of beta-lactamases. Antimicrob Agents Chemother. 1989 Mar;33(3):259–263. doi: 10.1128/aac.33.3.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bush K. Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'. Antimicrob Agents Chemother. 1989 Mar;33(3):264–270. doi: 10.1128/aac.33.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bush K., Sykes R. B. Methodology for the study of beta-lactamases. Antimicrob Agents Chemother. 1986 Jul;30(1):6–10. doi: 10.1128/aac.30.1.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Davies B. I., Maesen F. P. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):28–33. doi: 10.2165/00003495-198600313-00008. [DOI] [PubMed] [Google Scholar]
  10. Doern G. V., Siebers K. G., Hallick L. M., Morse S. A. Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother. 1980 Jan;17(1):24–29. doi: 10.1128/aac.17.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Eisenstein B. I., Sox T., Biswas G., Blackman E., Sparling P. F. Conjugal transfer of the gonococcal penicillinase plasmid. Science. 1977 Mar 11;195(4282):998–1000. doi: 10.1126/science.402693. [DOI] [PubMed] [Google Scholar]
  12. Eliasson I., Kamme C. Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. J Antimicrob Chemother. 1985 Feb;15(2):139–149. doi: 10.1093/jac/15.2.139. [DOI] [PubMed] [Google Scholar]
  13. Eliasson I., Kamme C., Prellner K. Beta-lactamase production in the upper respiratory tract flora. Eur J Clin Microbiol. 1986 Oct;5(5):507–512. doi: 10.1007/BF02017692. [DOI] [PubMed] [Google Scholar]
  14. Farmer T., Reading C. beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid. Antimicrob Agents Chemother. 1982 Mar;21(3):506–508. doi: 10.1128/aac.21.3.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HENRIKSEN S. D. Moraxella duplex var. nonliquefaciens, habitat and antibiotic sensitivity. Acta Pathol Microbiol Scand. 1958;43(2):157–161. doi: 10.1111/j.1699-0463.1958.tb04882.x. [DOI] [PubMed] [Google Scholar]
  16. Hansen W., Butzler J. P., Fuglesang J. E., Henriksen S. D. Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):318–322. doi: 10.1111/j.1699-0463.1974.tb02333.x. [DOI] [PubMed] [Google Scholar]
  17. Henriksen S. D. Moraxella, Acinetobacter, and the Mimeae. Bacteriol Rev. 1973 Dec;37(4):522–561. doi: 10.1128/br.37.4.522-561.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hoi-Dang A. B., Brive-Le Bouguenec C., Barthelemy M., Labia R. Novel beta-lactamase from Branhamella catarrhalis. Ann Microbiol (Paris) 1978 Oct;129 B(3):397–406. [PubMed] [Google Scholar]
  19. Jack G. W., Richmond M. H. A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria. J Gen Microbiol. 1970 Apr;61(1):43–61. doi: 10.1099/00221287-61-1-43. [DOI] [PubMed] [Google Scholar]
  20. Kamme C., Eliasson I., Knutson B. K., Vang M. Plasmid-mediated beta-lactamase in Branhamella catarrhalis. Drugs. 1986;31 (Suppl 3):55–63. doi: 10.2165/00003495-198600313-00013. [DOI] [PubMed] [Google Scholar]
  21. Kamme C., Vang M., Ståhl S. Transfer of beta-lactamase production in Branhamella catarrhalis. Scand J Infect Dis. 1983;15(2):225–226. doi: 10.3109/inf.1983.15.issue-2.17. [DOI] [PubMed] [Google Scholar]
  22. Kamme C., Wang M., Ståhl S. Intrageneric and intergeneric transfer of Branhamella catarrhalis beta-lactamase production. Scand J Infect Dis. 1984;16(2):153–155. doi: 10.3109/00365548409087134. [DOI] [PubMed] [Google Scholar]
  23. Kirven L. A., Thornsberry C. Transfer of beta-lactamase genes of Neisseria gonorrhoeae by conjugation. Antimicrob Agents Chemother. 1977 Jun;11(6):1004–1006. doi: 10.1128/aac.11.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kovatch A. L., Wald E. R., Michaels R. H. beta-Lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr. 1983 Feb;102(2):261–264. doi: 10.1016/s0022-3476(83)80537-x. [DOI] [PubMed] [Google Scholar]
  25. Labidi A. Restriction endonuclease analysis of total deoxyribonucleic acid of Mycobacterium tuberculosis H37RV (ATCC 27294) and of M. bovis (ATCC 19210). Arch Inst Pasteur Tunis. 1988 Jul-Oct;65(3-4):241–253. [PubMed] [Google Scholar]
  26. Luman I., Wilson R. W., Wallace R. J., Jr, Nash D. R. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production. Antimicrob Agents Chemother. 1986 Nov;30(5):774–776. doi: 10.1128/aac.30.5.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Maesen F. P., Davies B. I. Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):83–86. doi: 10.2165/00003495-198600313-00018. [DOI] [PubMed] [Google Scholar]
  28. Malmvall B. E., Brorsson J. E., Johnsson J. In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. J Antimicrob Chemother. 1977 Jul;3(4):374–375. doi: 10.1093/jac/3.4.374. [DOI] [PubMed] [Google Scholar]
  29. McDonald T. J., Pugh G. W., Jr Plasmid profiles of Moraxella bovis isolates. Am J Vet Res. 1986 Apr;47(4):964–966. [PubMed] [Google Scholar]
  30. McLeod D. T., Ahmad F., Croughan M. J., Calder M. A. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response. Drugs. 1986;31 (Suppl 3):109–112. doi: 10.2165/00003495-198600313-00023. [DOI] [PubMed] [Google Scholar]
  31. Moss C. W., Wallace P. L., Hollis D. G., Weaver R. E. Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis. J Clin Microbiol. 1988 Mar;26(3):484–492. doi: 10.1128/jcm.26.3.484-492.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nash D. R., Wallace R. J., Jr, Steingrube V. A., Udou T., Steele L. C., Forrester G. D. Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility. Am Rev Respir Dis. 1986 Dec;134(6):1276–1282. doi: 10.1164/arrd.1986.134.5.1276. [DOI] [PubMed] [Google Scholar]
  33. Nicotra B., Rivera M., Luman J. I., Wallace R. J., Jr Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med. 1986 May;146(5):890–893. [PubMed] [Google Scholar]
  34. Oberhofer T. R., Towle D. W. Evaluation of the rapid penicillinase paper strip test for detection of beta-lactamase. J Clin Microbiol. 1982 Feb;15(2):196–199. doi: 10.1128/jcm.15.2.196-199.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Percival A., Corkill J. E., Rowlands J., Sykes R. B. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet. 1977 Dec 3;2(8049):1175–1175. doi: 10.1016/s0140-6736(77)91562-8. [DOI] [PubMed] [Google Scholar]
  36. Philippon A., Riou J. Y., Guibourdenche M., Sotolongo F. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases. Drugs. 1986;31 (Suppl 3):64–69. doi: 10.2165/00003495-198600313-00014. [DOI] [PubMed] [Google Scholar]
  37. Reading C., Cole M. Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus. Antimicrob Agents Chemother. 1977 May;11(5):852–857. doi: 10.1128/aac.11.5.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rosenthal S. L., Freundlich L. F., Gilardi G. L., Clodomar F. Y. In vitro antibiotic sensitivity of Moraxella species. Chemotherapy. 1978;24(6):360–363. doi: 10.1159/000237808. [DOI] [PubMed] [Google Scholar]
  39. Saito A., Yamaguchi K., Shigeno Y., Kohno S., Shigeno H., Kusano N., Dotsu Y., Hara K. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections. Drugs. 1986;31 (Suppl 3):87–92. doi: 10.2165/00003495-198600313-00019. [DOI] [PubMed] [Google Scholar]
  40. Schurig G. G., Lightfoot D. R., Troutt H. F., Finkler B. I. Genotypic, phenotypic, and biological characteristics of Moraxella bovis. Am J Vet Res. 1984 Jan;45(1):35–39. [PubMed] [Google Scholar]
  41. Shurin P. A., Marchant C. D., Kim C. H., Van Hare G. F., Johnson C. E., Tutihasi M. A., Knapp L. J. Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis. 1983 Jan-Feb;2(1):34–38. doi: 10.1097/00006454-198301000-00009. [DOI] [PubMed] [Google Scholar]
  42. Shurin P. A., Van Hare G. F. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report. Drugs. 1986;31 (Suppl 3):122–124. doi: 10.2165/00003495-198600313-00027. [DOI] [PubMed] [Google Scholar]
  43. Simpson I. N., Plested S. J. The origin and properties of beta-lactamase satellite bands seen in isoelectric focusing. J Antimicrob Chemother. 1983 Aug;12(2):127–131. doi: 10.1093/jac/12.2.127. [DOI] [PubMed] [Google Scholar]
  44. Slevin N. J., Aitken J., Thornley P. E. Clinical and microbiological features of Branhamella catarrhalis bronchopulmonary infections. Lancet. 1984 Apr 7;1(8380):782–783. doi: 10.1016/s0140-6736(84)91288-1. [DOI] [PubMed] [Google Scholar]
  45. Smith P. K., Krohn R. I., Hermanson G. T., Mallia A. K., Gartner F. H., Provenzano M. D., Fujimoto E. K., Goeke N. M., Olson B. J., Klenk D. C. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985 Oct;150(1):76–85. doi: 10.1016/0003-2697(85)90442-7. [DOI] [PubMed] [Google Scholar]
  46. Snell J. J., Hill L. R., Lapage S. P. Identification and characterization of Moraxella phenylpyruvica. J Clin Pathol. 1972 Nov;25(11):959–965. doi: 10.1136/jcp.25.11.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Stobberingh E. E., Davies B. I., van Boven C. P. Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases. J Antimicrob Chemother. 1984 Jan;13(1):55–64. doi: 10.1093/jac/13.1.55. [DOI] [PubMed] [Google Scholar]
  48. Stobberingh E. E., van Eck H. J., Houben A. W., van Boven C. P. Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis. Drugs. 1986;31 (Suppl 3):23–27. doi: 10.2165/00003495-198600313-00007. [DOI] [PubMed] [Google Scholar]
  49. Van Hare G. F., Shurin P. A., Marchant C. D., Cartelli N. A., Johnson C. E., Fulton D., Carlin S., Kim C. H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. doi: 10.1093/clinids/9.1.16. [DOI] [PubMed] [Google Scholar]
  50. Wald E. R., Milmoe G. J., Bowen A., Ledesma-Medina J., Salamon N., Bluestone C. D. Acute maxillary sinusitis in children. N Engl J Med. 1981 Mar 26;304(13):749–754. doi: 10.1056/NEJM198103263041302. [DOI] [PubMed] [Google Scholar]
  51. Wilhelmsen L., Berglund G., Elmfeldt D., Samuelsson O., Svardsudd K. The Multifactor Primary Prevention Trial in Göteborg, Sweden. Comparison with a previously untreated population sample. Drugs. 1986;31 (Suppl 1):47–51. doi: 10.2165/00003495-198600311-00009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES